MSTN and cancer: The common effects of these inhibitors include increased muscle mass and strength with decreased fibrosis, and anti-myostatin therapies have been identified effective in several mouse models of muscle wasting associated with cancer and other disorders, even be approved in muscular dystrophies therapy (28, 29).